Research
Good Bacteria
Part 1
Induction of inflammation as a possible mechanism
of probiotic effect in atopic eczema-dermatitis syndrome
Abstract
Viljanen
M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M,
Sarnesto A, Vaarala O, Savilahti E.
Skin
and Allergy Hospital, University of Helsinki, Meilahdentie
2, 00250 Helsinki, Finland.
BACKGROUND:
The immunomodulating mechanisms of Lactobacillus
GG (LGG) and other probiotics are poorly understood.
OBJECTIVE: We studied in vivo the immunologic effects
of probiotics in infants with atopic eczema-dermatitis
syndrome (AEDS) and cow's milk allergy (CMA). METHODS:
Two hundred thirty infants with AEDS and suspected CMA
received, concomitant with elimination diet, either
LGG, a mixture of 4 probiotic strains (MIX), or placebo
for 4 weeks. All available paired pretreatment and posttreatment
plasma samples (n = 132) were analyzed for concentrations
of IL-2, IL-4, IL-6, IL-10, TNF-alpha, IFN-gamma, soluble
intercellular adhesion molecule 1, soluble E-selectin,
TGF-beta1, TGF-beta2, and C-reactive protein. RESULTS:
In infants with IgE-associated AEDS, treatment with
LGG induced higher C-reactive protein levels than in
the placebo group (geometric mean, 0.83 microg/mL [95%
CI, 0.56-0.81] vs 0.42 microg/mL [95% CI, 0.27-0.65];
P = .021). Concomitantly, IL-6 levels increased after
treatment with LGG ( P = .023) but not with MIX or placebo.
Soluble E-selectin levels were higher after probiotic
than after placebo treatment in infants with IgE-mediated
CMA (LGG geometric mean, 86.7 ng/mL [95% CI, 75.2-100];
MIX geometric mean, 91.6 ng/mL [95% CI, 74.8-111.9];
and placebo geometric mean, 64.9 ng/mL [95% CI, 53-79.3];
analysis of covariance, P = .035; LGG vs placebo, P
= .023; MIX vs placebo, P = .020). Use of MIX induced
an increase in plasma IL-10 levels ( P = .016). CONCLUSION:
Probiotics induced systemically detectable low-grade
inflammation, which might explain the clinical effects
of probiotics in AEDS and CMA.